Norcalciphos Injectable Solution 150 mg Solution is a Health Canada–registered veterinary drug (DIN 01915487) held by Pfizer Canada Inc Animal Health Group, containing Dextrose. Health Canada lists its status as Cancelled Post Market (status date 17 Jul 2013). Nexara Health has matched 380 registrations of Dextrose across 12 other regulated markets.
Health Canada registration
| DIN | 01915487 |
|---|---|
| Brand name | Norcalciphos Injectable Solution |
| Active ingredient | Dextrose |
| Strength | 150 mg |
| Dosage form | Solution |
| Route | Intravenous ; Subcutaneous |
| Company | Pfizer Canada Inc Animal Health Group |
| Status | Cancelled Post Market — 17 Jul 2013 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Dextrose registered in other markets
380 registrations of the same molecule in 12 national registries outside Canada (first 67 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Austria | Glucose 5 % "Fresenius" Plastikinf.fl. 250 ml | — | 10St | yellow box | eEKO (Erstattungskodex) | |
| Austria | Glucose 5 % "Fresenius" Plastikinf.fl. 500 ml | — | 10St | yellow box | eEKO (Erstattungskodex) | |
| Bahrain | 10 % W/V Dextrose Intravenous Infusion | Pharmaceutical Solution Industry Ltd (Psi), Ksa. | 10 % W/V | Solution For Infusion | POM | NHRA |
| Bahrain | 20% W/V Dextrose Intravenous Infusion | Pharmaceutical Solution Industry Ltd (Psi), Ksa. | 0.2 W/V | Solution For Infusion | POM | NHRA |
| Bahrain | 5% Dextrose | Pharmaceutical Solution Industry Ltd (Psi), Ksa. | 5 % | Solution For Infusion | POM | NHRA |
| Bahrain | 50% Dextrose | Pharmaceutical Solution Industry Ltd (Psi), Ksa. | 50 % | Solution For Infusion | POM | NHRA |
| Bahrain | 50% W/V Dextrose Intravenous Infusion | Pharmaceutical Solution Industry Ltd (Psi), Ksa. | 0.5 W/V | Solution For Infusion | POM | NHRA |
| Bahrain | Dexrtose | Kuwait Saudi Pharmaceutical Industries Co. (Kspico), Kuwait. | 40 % W/V | Solution For Infusion | POM | NHRA |
| Bahrain | Dextrose | Kuwait Saudi Pharmaceutical Industries Co. (Kspico), Kuwait. | 20 % W/V | Solution For Infusion | POM | NHRA |
| Bahrain | Dextrose 10% | Baxter Company Ltd, Ksa. | 10 % | Solution For Infusion | POM | NHRA |
| Czech Republic | Ardeanutrisol g 10% | — | 10% | Inf Sol | R | SUKL DLP |
| Czech Republic | Ardeanutrisol g 20% | — | 20% | Inf Sol | R | SUKL DLP |
| Czech Republic | Ardeanutrisol g 40% | — | 40% | Inf Sol | R | SUKL DLP |
| Czech Republic | Ardeanutrisol g 5% | — | 5% | Inf Sol | R | SUKL DLP |
| Czech Republic | Glucose Fresenius Kabi 10% | Fresenius Kabi s.r.o., Praha | 100MG/ML | Inf Sol | B | SUKL DLP |
| Czech Republic | Glucose Fresenius Kabi 20% | — | 200MG/ML | Inf Sol | R | SUKL DLP |
| Czech Republic | Glucose Fresenius Kabi 5% | — | 50MG/ML | Inf Sol | R | SUKL DLP |
| Czech Republic | Gluk�Za 10% Viaflo | — | 100MG/ML | Inf Sol | R | SUKL DLP |
| Greece | Dextrose/Cooper Sol.inf 5% (W/V) Bt X 1 (Pp) Bottle X 1000ml | Κοπερ Φαρμακοβιομηχανια Ανωνυμη Εταιρεια/Cooper Pharmaceuticals S.a. Δ.τ. Κοπερ Α.ε./Cooper S.a, Ελλαδα | reimbursed | MoH deltio timwn | ||
| Greece | Dextrose/Cooper Sol.inf 5% (W/V) Bt X 1 (Pp) Bottle X 100ml | Κοπερ Φαρμακοβιομηχανια Ανωνυμη Εταιρεια/Cooper Pharmaceuticals S.a. Δ.τ. Κοπερ Α.ε./Cooper S.a, Ελλαδα | reimbursed | MoH deltio timwn | ||
| Greece | Dextrose/Cooper Sol.inf 5% (W/V) Bt X 1 (Pp) Bottle X 250ml | Κοπερ Φαρμακοβιομηχανια Ανωνυμη Εταιρεια/Cooper Pharmaceuticals S.a. Δ.τ. Κοπερ Α.ε./Cooper S.a, Ελλαδα | reimbursed | MoH deltio timwn | ||
| Greece | Dextrose/Cooper Sol.inf 5% (W/V) Bt X 1 (Pp) Bottle X 500ml | Κοπερ Φαρμακοβιομηχανια Ανωνυμη Εταιρεια/Cooper Pharmaceuticals S.a. Δ.τ. Κοπερ Α.ε./Cooper S.a, Ελλαδα | reimbursed | MoH deltio timwn | ||
| Malta | DEXTROSE/VIOSER 5% w/v Solution for Infusion | Vioser S.A. Parenteral Solutions Industry | Solution For Infusion | Authorised | Medicines Authority | |
| Saudi Arabia | 10% Dextrose intravenous infusion | — | 10 | Inactive | SFDA | |
| Saudi Arabia | 10% DEXTROSE W/V intravenous infusion | — | 10 | Inactive | SFDA | |
| Saudi Arabia | 20%W/V DEXTROSE injection, USP | — | 20 | Inactive | SFDA | |
| Saudi Arabia | 25% w/v Dextrose | — | 25 | Inactive | SFDA | |
| Saudi Arabia | 25% W/V Dextrose Intravenous Infusion USP (1000ml Pp Bag) | — | 25 | Inactive | SFDA | |
| Saudi Arabia | 25% W/V Dextrose Intravenous Infusion USP (250ml Pp Bag) | — | 25 | Inactive | SFDA | |
| Saudi Arabia | 25% W/V Dextrose Intravenous Infusion USP (500ml Pe Bottle) | — | 25 | Inactive | SFDA | |
| Saudi Arabia | 25% W/V Dextrose Intravenous Infusion USP (500ml Pp Bag) | — | 25 | Inactive | SFDA | |
| Singapore | Dextrose 10% In Water For Intravenous Infusion | Joyson Pte. Ltd. | 10 g/100 ml | Injection | General Sale List | HSA |
| Singapore | Dextrose 5% In Water For Intravenous Infusion | Joyson Pte. Ltd. | 5 g/100 ml | Injection | General Sale List | HSA |
| Singapore | Dextrose Solution For I.v. Injection 50% | Joyson Pte. Ltd. | 500 mg/ml | Injection | General Sale List | HSA |
| South Africa | Dextrose 50% Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | 250 g/500 ml | Inf | S3 | DoH SEP database |
| South Africa | Dextrose 50% Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | 250 g/500 ml | Inf | S3 | DoH SEP database |
| South Africa | Dextrose 50% Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | 250 g/500 ml | Inf | S3 | DoH SEP database |
| South Africa | Dextrose 50% Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | 250 g/500 ml | Inf | S3 | DoH SEP database |
| South Africa | Dextrose 50% Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | 250 g/500 ml | Inf | S3 | DoH SEP database |
| South Africa | Dextrose Fresenius 50% (20Ml) | Bodene (Pty) Ltd | 10 g/20ml | Inj | S3 | DoH SEP database |
| South Africa | Electrolyte No. 2 with Dextrose 10% Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | 100 g/1000 ml | Inf | S3 | DoH SEP database |
| South Africa | Electrolyte No. 2 with Dextrose 10% Fresenius | Fresenius Kabi Manufacturing SA (Pty) Ltd | 100 g/1000 ml | Inf | S3 | DoH SEP database |
| Sri Lanka | *** | Ciron Drugs & PharmaceuticalS (Pvt) Ltd | INJECTION | Glass Amp.usp 1 &4ml | Full | NMRA |
| Taiwan | 10% Dextrose Injection "N.y." | 新喜國際企業股份有限公司 | 注射劑 | 已註銷 | TFDA | |
| Taiwan | 10% Dextrose Injection "Otsuka" | 台灣大塚製藥股份有限公司中壢工廠 | 注射劑 | Registered | TFDA | |
| Taiwan | 10% Glucose Injection "Chi Sheng" | 濟生醫藥生技股份有限公司 | 注射劑 | Registered | TFDA | |
| Taiwan | 20% Dextrose Injection "Astar" | 安星製藥股份有限公司 | 注射劑 | Registered | TFDA | |
| Taiwan | 20% Glucos Injection "Chi Sheng" | 濟生醫藥生技股份有限公司 | 注射劑 | Registered | TFDA | |
| Taiwan | 30% Dextrose Injection "S.y." | 壽元化學工業股份有限公司 | 注射劑 | 已註銷 | TFDA | |
| Taiwan | 5% Dextrose Injection "Astar" | 安星製藥股份有限公司 | 注射劑 | 已註銷 | TFDA | |
| Taiwan | 5% Dextrose Injection USP "Baxter" | Baxter Healthcare Of Puerto Rico | 注射劑 | 已註銷 | TFDA | |
| United Arab Emirates | 10% Dextrose Injection USP [Wellpharma] | WELLPHARMA MEDICAL SOLUTIONS LLC, United Arab Emirates, Abu Dhabi | 10% [10g/100ml] | Infusion | Active | EDE |
| United Arab Emirates | 10% Dextrose Injection USP [Wellpharma] | WELLPHARMA MEDICAL SOLUTIONS LLC, United Arab Emirates, Abu Dhabi | 10% [10g/100ml] | Infusion | Active | EDE |
| United Arab Emirates | 10% w/v Dextrose Injection, USP [Medisal] | MEDISAL PHARMACEUTICAL INDUSTRY LLC, United Arab Emirates, Abu Dhabi | 10% w/v | Injection | Active | EDE |
| United Arab Emirates | 25% w/v Dextrose Injection, USP [Medisal] | MEDISAL PHARMACEUTICAL INDUSTRY LLC, United Arab Emirates, Abu Dhabi | 25% w/v | Injection | Active | EDE |
| United Arab Emirates | 5% Dextrose Injection USP [Wellpharma] | WELLPHARMA MEDICAL SOLUTIONS LLC, United Arab Emirates, Abu Dhabi | 5% [5g/100ml] | Infusion | Active | EDE |
| United Arab Emirates | 5% Dextrose Injection USP [Wellpharma] | WELLPHARMA MEDICAL SOLUTIONS LLC, United Arab Emirates, Abu Dhabi | 5% [5g/100ml] | Infusion | Active | EDE |
| United Arab Emirates | 5% Dextrose Injection USP [Wellpharma] | WELLPHARMA MEDICAL SOLUTIONS LLC, United Arab Emirates, Abu Dhabi | 5% [5g/100ml] | Infusion | Active | EDE |
| United Arab Emirates | 5% Dextrose Injection USP [Wellpharma] | WELLPHARMA MEDICAL SOLUTIONS LLC, United Arab Emirates, Abu Dhabi | 5% [5g/100ml] | Infusion | Active | EDE |
| United States | Dextrose | ICU Medical, Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Dextrose | ProPharma Distribution | Injection, Solution | listed | FDA NDC | |
| United States | Dextrose | B. Braun Medical Inc. | Solution | listed | FDA NDC | |
| United States | Dextrose | Hospira, Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Dextrose | Hospira, Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Dextrose | ICU Medical Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Dextrose | ICU Medical Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Dextrose | ICU Medical, Inc. | Injection, Solution | listed | FDA NDC |
See every manufacturer of Dextrose worldwide →
Regulator price references for Dextrose
Published list or reimbursement prices for Dextrose presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Austria | Glucose 5 % "Fresenius" Plastikinf.fl. 500 ml | 500ml+5pct | 10St | 13.70 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Glucose 5 % "Fresenius" Plastikinf.fl. 250 ml | 250ml+5pct | 10St | 13.70 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Dextrose 5% W/V Iv Infusion | 5pct | 500ML | 0.58 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dextrose 10% | 10pct | 500ML | 0.58 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dextrose 10% | 10pct | 250ML | 0.58 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dextrose 5% In Viaflex | 5pct | 250ML | 0.58 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | 50% Dextrose | 50pct | 50ML | 0.61 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dextrose 10% W/V | 10pct | 500ML | 0.63 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dextrose | 20pct | 500ML | 0.67 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dextrose 5% In Viaflex | 5pct | 500ML | 0.67 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | 10 % W/V Dextrose Intravenous Infusion | 10pct | 500ML | 0.67 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | 5% Dextrose | 5pct | 500ML | 0.76 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dexrtose | 40pct | 500ML | 0.84 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dextrose 5% In Viaflex | 5pct | 1000ML | 0.88 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dextrose 10% | 10pct | 1000ML | 1.00 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | 20% W/V Dextrose Intravenous Infusion | 20pct | 500 ML | 1.53 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | 50% W/V Dextrose Intravenous Infusion | 50pct | 500 ML | 1.65 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dextrose 5% W/V | 5pct | 500ML | 10.38 BHD | retail (max) | NHRA | 2026-09-01 |
| Greece | Dextrose/Cooper Sol.inf 5% (W/V) Bt X 1 (Pp) Bottle X 250ml | 250ml+5pct | 0.85 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Dextrose/Cooper Sol.inf 5% (W/V) Bt X 1 (Pp) Bottle X 100ml | 100ml+5pct | 0.87 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Dextrose/Cooper Sol.inf 5% (W/V) Bt X 1 (Pp) Bottle X 500ml | 500ml+5pct | 1.01 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Dextrose/Cooper Sol.inf 5% (W/V) Bt X 1 (Pp) Bottle X 1000ml | 1000ml+5pct | 1.20 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Saudi Arabia | Dextrose | 3.40 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Dextrose 10% I.v.infusion | 10pct | 3.40 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 5% Inj | 5pct | 3.40 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 5% Inj | 5pct | 4.10 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% Inj | 10pct | 4.25 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% Solution For Inj | 10pct | 4.30 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% Inj | 10pct | 4.35 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% Inj | 10pct | 4.70 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% Inj | 10pct | 4.80 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose | 4.85 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Dextrose 10% I.v.infusion | 10pct | 5.40 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 5% | 5pct | 5.75 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 5% Infusion | 5pct | 5.80 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 5% | 5pct | 6.10 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% | 10pct | 6.15 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 5% I.v Infusion | 5pct | 6.20 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 5% Solution For Iv Infusion In Viaflex | 5pct | 6.35 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 5% Solution For Iv Infusion In Viaflex | 5pct | 6.35 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% Solution For Iv Infusion In Viaflex | 10pct | 6.40 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% Solution For Iv Infusion In Viaflex | 10pct | 6.40 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% I.v.infusion | 10pct | 6.40 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | 10% Dextrose intravenous infusion | 10pct | 6.50 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% Inj | 10pct | 6.75 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% | 10pct | 7.00 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% I.v.infusion | 10pct | 7.50 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 5% | 5pct | 7.50 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% | 10pct | 7.55 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | 25% w/v Dextrose | 25pct | 8.05 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% I.v.infusion | 10pct | 9.25 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% Inj | 10pct | 10.25 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% I.v.infusion | 10pct | 10.30 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 5% Solution For Iv Infusion In Viaflex | 5pct | 10.75 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dextrose 10% Solution For Iv Infusion In Viaflex | 10pct | 11.10 SAR | public | SFDA | 2026-09-01 | |
| United Arab Emirates | 5% W/V DEXTROSE INJECTION USP [Medisal] | 5000mg/100ml | 50ml in plastic Bag | 2.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 50% w/v DEXTROSE INJECTION, USP [Medisal] | 50000mg/100ml | 50 mL Polypropylene Bottle | 2.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 5% W/V DEXTROSE INJECTION USP [Medisal] | 5000mg/100ml | 100ml in plastic Bag | 3.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 5% W/V DEXTROSE INJECTION USP [Medisal] | 5000mg/100ml | 50ml in plastic Bottle | 3.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 50% w/v DEXTROSE INJECTION, USP [Medisal] | 50000mg/100ml | 100 mL Polypropylene Bottle | 3.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 5% Dextrose Injection USP [Wellpharma] | 5000mg/100ml | 50 ml bag | 4.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 5% W/V DEXTROSE INJECTION USP [Medisal] | 5000mg/100ml | 250ml in plastic Bag | 4.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 5% Dextrose Injection USP [Wellpharma] | 5000mg/100ml | 100 ml bag | 4.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 50% w/v DEXTROSE INJECTION, USP [Medisal] | 50000mg/100ml | 250 mL Polypropylene Bottle | 4.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 5% W/V DEXTROSE INJECTION USP [Medisal] | 5000mg/100ml | 100ml in plastic Bottle | 4.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 5% W/V DEXTROSE INJECTION USP [Medisal] | 5000mg/100ml | 250ml in plastic Bottle | 5.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 5% W/V DEXTROSE INJECTION USP [Medisal] | 5000mg/100ml | 500mL in plastic Bottle | 5.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 5% W/V DEXTROSE INJECTION USP [Medisal] | 5000mg/100ml | 500ml in plastic Bag | 5.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 5% Dextrose Injection USP [Wellpharma] | 5000mg/100ml | 500 ml Bag | 5.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 5% Dextrose Injection USP [Wellpharma] | 5000mg/100ml | 250 ml bag | 5.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 10% w/v Dextrose Injection, USP [Medisal] | 10pct | 500 ml in plastic Bottle | 5.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 10% Dextrose Injection USP [Wellpharma] | 10000mg/100ml | 500 ml Bag | 5.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 50% Dextrose Injection USP [Wellpharma] | 500mg/1ml | 50 mL Polypropylene Bag | 5.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 25% w/v Dextrose Injection, USP [Medisal] | 25pct | 500 mL Polypropylene Bottle | 5.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 50% Dextrose Injection USP [Wellpharma] | 500mg/1ml | 100 mL Polypropylene Bag | 7.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 10% Dextrose Injection USP [Wellpharma] | 10000mg/100ml | 1000 ml Bag | 7.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 5% Dextrose Injection USP [Wellpharma] | 5000mg/100ml | 1000 ml Bag | 7.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 5% W/V DEXTROSE INJECTION USP [Medisal] | 5000mg/100ml | 1000ml in plastic Bag | 7.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 50% Dextrose Injection USP [Wellpharma] | 500mg/1ml | 500 mL Polypropylene Bag | 8.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 50% w/v DEXTROSE INJECTION, USP [Medisal] | 50000mg/100ml | 500 mL Polypropylene Bottle | 10.50 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Norcalciphos Injectable Solution (DIN 01915487) marketed in Canada?
No. Health Canada lists DIN 01915487 as Cancelled Post Market as of 17 Jul 2013.
Who holds the Canadian licence for this product?
Pfizer Canada Inc Animal Health Group is the company of record in the Health Canada Drug Product Database.
Is Dextrose registered outside Canada?
Yes — Nexara Health has matched 380 registrations in 12 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 01915487, status date 2013-07-17; national medicine registries: DoH SEP database, EDE, eEKO (Erstattungskodex), FDA NDC, HSA, Medicines Authority, MoH deltio timwn, NHRA, NMRA, SFDA, SUKL DLP, TFDA; price sources: EDE, eEKO (Erstattungskodex), MoH deltio timwn, NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 01915487, status date 2013-07-17; national medicine registries: DoH SEP database, EDE, eEKO (Erstattungskodex), FDA NDC, HSA, Medicines Authority, MoH deltio timwn, NHRA, NMRA, SFDA, SUKL DLP, TFDA; price sources: EDE, eEKO (Erstattungskodex), MoH deltio timwn, NHRA, SFDA.
Pfizer Canada Inc Animal Health Group — company profileWho else makes DextroseAll Canadian Dextrose products
Health Canada Drug Product Database (DPD), DIN 01915487, status date 2013-07-17; national medicine registries: DoH SEP database, EDE, eEKO (Erstattungskodex), FDA NDC, HSA, Medicines Authority, MoH deltio timwn, NHRA, NMRA, SFDA, SUKL DLP, TFDA; price sources: EDE, eEKO (Erstattungskodex), MoH deltio timwn, NHRA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.